John J. LaFrancois - Concepedia

Author

John J. LaFrancois

Nathan Kline Institute for Psychiatric Research

Also Known As

J. LaFrancois, J. Lafrancois, John J LaFrancois, John J. LaFrancois, John LaFrancois, John Lafrancois, John J. LaFrancois

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Nathan Kline Institute for Psychiatric Research New York University NYU Langone Health Columbia University Mayo Clinic in Florida

About

John J. LaFrancois is an author at Nathan Kline Institute for Psychiatric Research specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	3.6K
2	Social Sciences	7	7	475
3	Health Sciences	2	2	1K
4	Natural Sciences	1	1	500
5	Biochemistry	1	1	114

John J. LaFrancois

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model Lorenzo M. Refolo, Miguel A. Pappolla, Brian Malester, Neurobiology of Disease Alzheimer's DiseaseDementiaVascular DementiaDegenerative PathologyNeurochemical Biomarkers	2000	992
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration<i>in vivo</i> Wendy Noble, Emmanuel Planel, Cindy Zehr, Proceedings of the National Academy of Sciences	2005	687
A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease Lorenzo M. Refolo, Miguel A. Pappolla, John J. LaFrancois, Neurobiology of Disease Neurodegenerative DiseasesAlzheimer's DiseaseMedicineDegenerative PathologyNeurology	2001	516
Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo Wendy Noble, Vicki Olm, Kazuyuki Takata, Neuron Tau AggregationProtein FunctionSignal TransductionSignaling PathwayProtein Folding	2003	500
Novel Therapeutic Approach for the Treatment of Alzheimer's Disease by Peripheral Administration of Agents with an Affinity to β-Amyloid Yasuji Matsuoka, John J. LaFrancois, Mariko Saito, Journal of Neuroscience ImmunologyNeurochemical BiomarkersImmunotherapyNovel Therapeutic ApproachNeuroinflammation	2003	324
proBDNF Negatively Regulates Neuronal Remodeling, Synaptic Transmission, and Synaptic Plasticity in Hippocampus Jianmin Yang, Lauren C. Harte‐Hargrove, Chia-Jen Siao, Cell Reports	2014	319
Inflammatory Responses to Amyloidosis in a Transgenic Mouse Model of Alzheimer’s Disease Yasuji Matsuoka, Melanie Picciano, Brian Malester, American Journal Of Pathology InflammationInflammatory ResponsesNeurodegenerative DiseasesAlzheimer's DiseaseMedicine	2001	304
Lack of Nigral Pathology in Transgenic Mice Expressing Human α-Synuclein Driven by the Tyrosine Hydroxylase Promoter Yasuji Matsuoka, Miquel Vila, Sarah Lincoln, Neurobiology of Disease Knockout MouseNeurodegenerative DiseasesMedicineGeneticsTyrosine Hydroxylase Promoter	2001	278
Modulation of Aβ peptides by estrogen in mouse models Hui Zheng, Huaxi Xu, Sacha Uljon, Journal of Neurochemistry	2001	175
Presenilin Redistribution Associated with Aberrant Cholesterol Transport Enhances β-Amyloid Production<i>In Vivo</i> Mark P. Burns, Kate Gaynor, Vicki Olm, Journal of Neuroscience	2003	174

Page 1